Importance of the C-Reactive Protein to Albumin Ratio in the Diagnosis and Prognosis of Mycosis Fungoides

Importance of the C-Reactive Protein to Albumin Ratio in the Diagnosis and Prognosis of Mycosis Fungoides

Authors

  • Gamze Taş-Aygar Universty of Health Sciences, Etlik City Hospital, Dermatology Clinic, Ankara, Turkey
  • Hatice Ataş Universty of Health Sciences, Etlik City Hospital, Dermatology Clinic, Ankara, Turkey
  • Müzeyyen Gönül Universty of Health Sciences, Etlik City Hospital, Dermatology Clinic, Ankara, Turkey
  • Selda Pelin Kartal

Keywords:

dermoscopy, Chilel, dermatologist, useful

Abstract

Introduction: CRP/albümin ratio (CAR) has been lately demonstrated as a prognostic factor and an indicator of disease activity, severity and prognosis in solid organ malignancies and inflammatory diseases. However, the effects of CAR have not been investigated in mycosis fungoides (MF) patients yet. This study aimed to determine the potential role of CAR as a diagnostic and a prognostic indicator in MF.

Methods:We retrospectively investigated the electronic medical records of 97 patients with MF admitted to the Dermatology Clinic of Ankara Diskapi Yildirim Beyazit Training and Research Hospital between January 2014 and December 2020. In total, 60 patients with MF were enrolled in the study. CAR was evaluated, patient and control group. Also, the other clinicopathological factors including age, lactate dehydrogenase, stage of disease, beta-2-microglobulin levels, and sedimentation levels were evaluated.

Results: The median value of CAR was 0.85 (0.10-7.51) in the patient group, whereas it was 0.39 (0.0-1.11)in the control group(P<0.001). Patients with disease progression (N:16, 13M, 3 F) had a median value of CAR 0.84 (0.10-7.51) and the median value of CAR (N:44) was 0.86 (0.12-4.57) in the group of patients with stable disease. The CAR value had no prognostic significance (P>0.05).

Conclusion: There is no association between the CAR and progression in the stage in MF patients. But the CAR is significantly higher in patients with MF than in the control group. The CAR can be a guide for us in cases where we have difficulty in diagnosing.

References

Hodak E, Amitay-Laish I. Mycosis fungoides: A great imitator. Clinics in Dermatology [Internet]. 2019;37(3):255–67. Available from: https://doi.org/10.1016/j.clindermatol.2019.01.004

Maguire A, Puelles J, Raboisson P, Chavda R, Gabriel S, Thornton S. Early-stage mycosis fungoides: Epidemiology and prognosis. Acta Dermato-Venereologica. 2020;100(1):1–6.

Hristov AC, Tejasvi T, Wilcox RA. Mycosis fungoides and Sézary syndrome: 2019 update on diagnosis, risk-stratification, and management. American Journal of Hematology. 2019;94(9):1027–41.

Larocca C, Kupper T. Mycosis Fungoides and Sézary Syndrome: An Update. Hematol Oncol Clin North Am. 2019;33(1):103–20.

Kocatürk M KÖ. Assessment of relationship between C-reactive protein to albumin ratio and 90-day mortality in patients with acute ischaemic stroke. Neurol Neurochir Pol. 2019;53(3):205–11.

Akkececi NS, Cetin GY, Gogebakan H, Acipayam C. The C-reactive protein/albumin ratio and complete blood count parameters as indicators of disease activity in patients with takayasu arteritis. Medical Science Monitor. 2019;25:1401–9.

Fu YJ, Li KZ, Bai JH, Liang ZQ. C-reactive protein/albumin ratio is a prognostic indicator in Asians with pancreatic cancers: A meta-analysis. Medicine (United States). 2019;98(48):1–8.

Tamer F, Avcı E. Serum C-reactive protein to albumin ratio as a novel inflammation biomarker in psoriasis patients treated with adalimumab, ustekinumab, infliximab, and secukinumab: A retrospective study. Croatian Medical Journal. 2020;61(4):333–7.

Kaplan M, Ates I, Akpinar MY, Yuksel M, Kuzu UB, Kacar S, et al. Predictive value of C-reactive protein/albumin ratio in acute pancreatitis. Hepatobiliary and Pancreatic Diseases International [Internet]. 2017;16(4):424–30. Available from: http://dx.doi.org/10.1016/S1499-3872(17)60007-9

Kim MH, Ahn JY, Song JE, Choi H, Ann HW, Kim JK, et al. The C-reactive protein/albumin ratio as an independent predictor of mortality in patients with severe sepsis or septic shock treated with early goal-directed therapy. PLoS ONE. 2015;10(7):1–13.

Kalyoncuoglu M, Durmus G. Relationship between C-reactive protein-to-albumin ratio and the extent of coronary artery disease in patients with non-ST-elevated myocardial infarction. Coronary Artery Disease. 2020;31(2):130–6.

Kim Y, Park Y, Park Y. C-reactive protein/albumin ratio as an indicator of disease activity in Behçet’s disease and human leukocyte antigen-B27-associated uveitis. Graefes Arch Clin Exp Ophthalmol. 2021;30.

Bozkurt E, Muhafiz E, Sengul D, Uçak T, Atum M. Can the CRP/albumin Ratio be Used as a New Indicator of Activation in Patients with Uveitis? Ocular Immunology and Inflammation [Internet]. 2020;00(00):1–6. Available from: https://doi.org/10.1080/09273948.2020.1714061

Olsen E, Vonderheid E, Pimpinelli N, Willemze R, Kim Y, Knobler R, et al. Revisions to the staging and classification of mycosis fungoides and Sezary syndrome : a proposal of the International Society for Cutaneous Lymphomas ( ISCL ) and the cutaneous lymphoma task force of the European Organization of Research and Treatment. Blood [Internet]. 2007;110(6):1713–22. Available from: http://dx.doi.org/10.1182/blood-2007-03-055749

Krejsgaard T, Lindahl LM, Mongan NP, Wasik MA, Litvinov I V., Iversen L, et al. Malignant inflammation in cutaneous T‐cell lymphoma—a hostile takeover. Seminars in Immunopathology [Internet]. 2017;39(3):269–82. Available from: http://dx.doi.org/10.1007/s00281-016-0594-9

van Doorn R, Van Haselen C, van Voorst Vader P, Geerts M, Heule F, de Rie M, et al. Mycosis fungoides: disease evolution and prognosis of 309 Dutch patients. Arch Dermatol. 2000;136(4):504–10.

Kim Y, Jensen R, Watanabe G, Varghese A, Hoppe R. Clinical stage IA (limited patch and plaque) mycosis fungoides: A long-term outcome analysis. Arch Dermatol. 1996;132(11):1309–13.

Bahalı AG, Su O, Cengiz FP, Emiroğlu N, Ozkaya DB, Onsun N. Prognostic factors of patients with mycosis fungoides. Postepy Dermatologii i Alergologii. 2020;37(5):796–9.

Cengiz FP, Emiroglu N, Ozkaya DB, Bahali AG, Su O, Onsun N. Prognostic evaluation of neutrophil/lymphocyte ratio in patients with mycosis fungoides. Annals of Clinical and Laboratory Science. 2017;47(1):25–8.

Nikolaou V, Papadavid E, Patsatsi A, Siakantaris M, Economidi A, Marinos L, et al. Prognostic indicators for mycosis fungoides in a Greek population. British Journal of Dermatology. 2017;176(5):1321–30.

Haase R, Vilser C, Mauz-Körholz C, Hasenclever D, Kluge R, Ruschke K, et al. Evaluation of the prognostic meaning of C-reactive protein (CRP) in children and adolescents with classical hodgkins lymphoma (HL). Klinische Padiatrie. 2012;224(6):377–81.

Wieland A, Kerbl R, Berghold A, Schwinger W, Mann G, Urban C. C-reactive protein (CRP) as tumor marker in pediatric and adolescent patients with Hodgkin disease. Medical and Pediatric Oncology. 2003;41(1):21–5.

Allin KH, Nordestgaard BG. Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer. Critical Reviews in Clinical Laboratory Sciences. 2011;48(4):155–70.

Gobbi PG, Gendarini A, Crema A, Cavalli C, Attardo-Parrinello G, Federico M, Di Prisco U AE. Serum albumin in Hodgkin’s disease. Cancer. 1985;55(2):389–93.

Bairey O, Shacham-Abulafia A, Shpilberg O GR. Serum albumin level at diagnosis of diffuse large B-cell lymphoma: an important simple prognostic factor. Hematological oncology. 2016;34(4):184–92.

Gupta D, Lis CG. Pretreatment serum albumin as a predictor of cancer survival: A systematic review of the epidemiological literature. Nutrition Journal [Internet]. 2010;9(1):69. Available from: http://www.nutritionj.com/content/9/1/69

Liu Z, Jin K, Guo M, Long J, Liu L, Liu C, et al. Prognostic Value of the CRP/Alb Ratio, a Novel Inflammation-Based Score in Pancreatic Cancer. Annals of Surgical Oncology. 2017;24(2):561–8.

Vujic J, Marsoner K, Wienerroither V, Mischinger HJ, Kornprat P. The predictive value of the CRP-to-albumin ratio for patients with pancreatic cancer after curative resection: A retrospective single center study. In Vivo. 2019;33(6):2071–8.

Fan Z, Fan K, Gong Y, Huang Q, Yang C, Cheng H, et al. The CRP/albumin ratio predicts survival and monitors chemotherapeutic effectiveness in patients with advanced pancreatic cancer. Cancer Management and Research. 2019;11:8781–8.

Zhou L, Ma S, Balde AI, Han S, Cai Z, Li Z. A retrospective propensity score matched study of the preoperative c-reactive protein to albumin ratio and prognosis in patients with resectable non-metastatic breast cancer. Medical Science Monitor. 2019;25:4342–52.

Ju SY, Ma SJ. High C-reactive protein to albumin ratio and the short-term survival prognosis within 30 days in terminal cancer patients receiving palliative care in a hospital setting: A retrospective analysis. Medicine (United States). 2020;99(9):1–7.

Downloads

Published

2024-04-30

How to Cite

1.
Importance of the C-Reactive Protein to Albumin Ratio in the Diagnosis and Prognosis of Mycosis Fungoides. Dermatol Pract Concept [Internet]. 2024 Apr. 30 [cited 2024 Dec. 9];14(2):e2024097. Available from: https://dpcj.org/index.php/dpc/article/view/3332

Share